LRIT3 Antikörper (AA 50-573)
Kurzübersicht für LRIT3 Antikörper (AA 50-573) (ABIN7875413)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 50-573
-
Verwendungszweck
- LRIT3 Antibody
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- An E.coli-derived human recombinant protein (amino acids E50-R573) was used as the immunogen for the LRIT3 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the LRIT3 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the LRIT3 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- LRIT3 (Leucine-Rich Repeat, Immunoglobulin-Like and Transmembrane Domains 3 (LRIT3))
-
Andere Bezeichnung
- LRIT3
-
Hintergrund
- Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 is a protein that in humans is encoded by the LRIT3 gene. This gene encodes a protein that has a fibronectin type III domain and a C-terminal transmembrane domain, as well as a leucine-rich repeat domain and immunoglobulin-like domain near the N-terminus. The encoded protein may regulate fibroblast growth factor receptors and affect the modification of these receptors, which are glycosylated differently in the Golgi and endoplasmic reticulum. Mutations in this gene are associated with congenital stationary night blindness, type 1F.
-
UniProt
- Q3SXY7
Target
-